Coronary and Heart Effects of Early Treatment in Familial Hypercholesterolemia
NCT ID: NCT05352386
Last Updated: 2023-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
135 participants
INTERVENTIONAL
2022-03-07
2022-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population
NCT04958629
a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia
NCT03398954
Cardiovascular Disease in FH Heterozygous
NCT01783405
Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic
NCT05638022
Proteomics and Genomics Combined With CT to Predict CVD
NCT05800093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with familial hypercholesterolemia, early treated
Coronary computed tomography angiography (CCTA)
Participants undergo coronary computed tomography angiography (CCTA)
Patients without familial hypercholesterolemia, late treated
Coronary computed tomography angiography (CCTA)
Participants undergo coronary computed tomography angiography (CCTA)
Healthy individuals
Coronary computed tomography angiography (CCTA)
Participants undergo coronary computed tomography angiography (CCTA)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coronary computed tomography angiography (CCTA)
Participants undergo coronary computed tomography angiography (CCTA)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients between 25 and 55 years old.
Exclusion Criteria
* Atrial fibrillation
* Any other treatment or clinically relevant condition that could interfere with the conduct or interpretation of the study in the opinion of the investigator
* Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study.
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dutch Heart Foundation
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
E.S.stroes
Prof. dr. E.S.G.Stroes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC, location AMC
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL79640.018.21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.